141

7. References

Acarturk, F. (2009). Mucoadhesive vaginal drug delivery systems. Recent Patents on

Drug Delivery & Formulations 3: 193-205.

Ader, M. and Bergman, R. N. (1990). Peripheral effects of insulin dominate

suppression of fasting hepatic glucose production. Americal Journal of Physiology

258: E1020-E1032.

Agarwal, V. and Khan, M. A. (2001). Current status of the oral delivery of insulin.

Pharmaceutical Technology Oct: 76-90.

Al-Achi, A., and Greenwood, R. (1993). Buccal administration of human insulin in

streptozocindiabetic rats. Researsh Communications in Chemical Pathology and

Pharmacology 82: 297-306.

Al-Shawi M. K., Urbatsch I. L. and Senior A. E. (1994) Covalent inhibitors of P-

glycoprotein ATPase activity. Journal of Biological Chemistry 269: 8986–8992.

Anderberg, E. K., Lindmark, T. and Artursson, P. (1993). Sodium caprate elicits

dilatation in human intestinal tight junctions and enhances drug absorption by the

paracellular route. Pharmaceutical Research 10: 857-864.

Andrew, G. P., Laverty, T. P. and Jones, D. S. (2009). Mucoadhesive polymeric for

controlled drug delivery. European Journal of Pharmaceutics and Biopharmaceutics

71: 505-518.

Aref, I., El-Sheikha, Z. and Hafez, E. S. E. (1978). Absorption of drugs and hormones

in the vagina.In: Hafez, E. S. E. and Evans, T. N. (eds). The human vagina. pp 179.

Amsterdam: Elsevier/North Holland Publishing Co., New York.

Armstrong, N. A. and James, K. C. (1996). Pharmaceutical experimental design and

interpretation. pp 38-43. Taylor and Fancis Inc., Bristol, PA.

Ashford, M. and Fell, J. T. (1993). Colonic delivery of drugs. Current status on

targeted drug delivery to the gastrointestinal tract. Capsugel, Symposia Series. pp 133-

142. Short Hills, NJ.

Aungst, B. J., and Rogers, N. J. (1989). Comparison of the effects of various

transmucosal absorption promoters on buccal insulin delivery. International Journal

of Pharmaceutics 53: 227-235.

Aungst, B. J., Saitoh, H., Burcham, D. L., Huang, S. M., Mousa, S. A. and Hussain,

M. A. (1996). Enhancement of the intestinal absorption of peptides and non-peptides.

Journal of Controlled Release 41: 19-31.

Baker, J., Hidalgo, I. J. and Borchardt, R. T. (1991). Intestinal epithelial and vascular

endothelial barriers to peptide and protein drug delivery. In Lee V. H. L. (eds).

Peptide and protein drug delivery. pp 359-390. Marcel Dekker, New York.

142

Balthasar, S., Michaelis, K., Dinauer, N., von Briesen, H., Kreuter, J. and Langer, K.

(2005). Preparation and characterisation of antibody modified gelatin nanoparticles as

drug carrier system for uptake in lymphocytes. Biomaterials 26: 2723–2732.

Baluom, M., Friedman, M. and Rubinstein, A. (2001). Improved intestinal absorption

of sulpiride in rats with synchronized oral delivery systems. Journal of Controlled

Release 70: 139-147.

Banga, A. K. (1999). Therapeutic Peptides and Proteins. pp 529. Technomic

Publication, Cancaster.

Barbault-Foucher, S., Gref, R. Russo, P., Guechot, J. and Bochot, A. (2002). Design

of poly-epsilon-caprolactone nanospheres coated with bioadhesive hyaluronic acid for

ocular delivery. Journal of Controlled Release 83: 365–75.

Bardelmeijer, H. A., Beijnen, J. H., Brouwer, K. R., Rosing, H., Nooijen, W. J.,

Schellens, J. H. and van Tellingen, O. (2000). Increased oral bioavailability of

paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.

Clinical Cancer Research 6:4416–4421.

Bar-On, H., Berry, E. M., Eldor, A., Kidron, M., Lichtenberg, D. and Ziv, E. (1981).

Enteral administration of insulin in the rat. British Journal of Pharmacology 73: 21-

24.

Batrakova, E. V., Han, H. Y., Alakhov, V. Y., Miller, D. W. and Kabanov, A. V.

(1998). Effects of pluronic block copolymers on drug absorption in Caco-2 cell

monolayers. Pharmaceutical Research 15: 850–855.

Bell, C. L., Peppas, N. A. (1996). Water, solute and protein diffusion in

physiologically-responsive hydrogels of poly(methacrylic acid-g-ethylene glycol).

Biomaterials 17: 1203-1218.

Bendayan, M., Ziv, E., Ben-Sasson, R., Bar-On, H. and Kidron, M. (1990). Morpho-

cytochemical and biochemical evidence for insulin absorption by the rat ileal

epithelium. Diabetologia 33: 197-204.

Bendayan, M., Ziv, E., Gingras, D., Ben-Sasson, R., Bar-On, H. and Kidron, M.

(1994). Biochemical and morpho-cytochemical evidence for the intestinal absorption

of insulin in control and diabetic rats. Comparison between the effectiveness of

duodenal and colon mucosa, Diabetologia 37: 119-126.

Berg, J. M., Tymoczko, J. L. and Stryer, L. (2007). Biochemistry. pp 231-232. W. H.

Freeman and Company, New York.

Bergeron, J. J., Rachubinski, R., Searle, N., Borts, D., Sikstrom, R. and Posner, B. I.

(1980). Polypeptide hormone receptors in vivo: Demonstration of insulin binding to

adrenal gland and gastrointestinal epithelium by quantitative radioautography.

Journal of Histochemistry and Cytochemistry 28: 824-835.

143

Bernkop-Schnurch, A. (2000). Chitosan and its derivatives: potential excipients for

peroral peptide delivery systems. International Journal of Pharmaceutics 194: 1-13.

Bernkop-Schnurch, A. (2005). Thiomers: A new generation of mucoadhesive

polymers. Advanced Drug Delivery Reviews 57: 1569–1582.

Bernkop-Schnurch, A., Brandt, U. M., and Clausen, A. E. (1999). Synthesis and in

vitro evaluation of chitosan-cysteine conjugates. Scientia Pharmaceutica 67: 196–

208.

Bernkop-Schnurch, A. and Fragner, R (1996). Investigations into the diffusion

behaviour of polypeptides in native intestinal mucus with regard to their peroral

administration. Pharmacy and Pharmacology Communications 2: 361-363.

Bernkop-Schnurch, A. and Grabovac, V. (2006). Polymeric efflux pump inhibitors in

oral drug delivery. American Journal of Drug Delivery 4: 263-272.

Bernkop-Schnurch, A., Guggi, D. and Pinter, Y. (2004). Thiolated chitosans:

development and in vivo evaluation of a mucoadhesives permeation enhancing oral

drug delivery system. Journal of Controlled Release 94: 177-186.

Bernkop-Schnurch, A., Hornof, M. and Zoidl, T. (2003). Thiolated polymers-

thiomers: modification of chitosan with 2-iminothiolane. International Journal of

Pharmacy 260: 229–237.

Bernkop-Schnurch, A. and Marschutz, M. K. (1997). Development and in vivo

evaluation of systems to protect peptide drugs from aminopeptidase N.

Pharmaceutical Research 14: 181-185.

Bernkop-Schnurch, A., Scholler, S. and Biebel, R. G. (2000). Development of

controlled drug release systems based on thiolated polymers. Journal of Controlled

Release 66: 39–48.

Bernkop-Schnurch, A., Walker, G. and Zarti, H. (2001). Thiolation of polycarbophil

enhances its inhibition of intestinal brush border membrane bound aminopeptidase N.

Journal of Pharmaceutical Sciences 90: 1907–1914.

Biocon (2009a). Biocon, Discovery pipeline.

<http://www.biocon.com/biocon_research_pipeline.asp >. Accessed 2010 Jun, 04.

Biocon (2009b). Biocon, Active discovery progams. <http:

//www.biocon.com/biocon_research_discovery.asp >. Accessed 2010 Jun, 04.

Birchall, J. C. (2007). Stratum corneum bypassed or removed. In: Touitou, E. and

Barry, B. W. (eds). Enhacement in Drug Delivery. pp. 339-343. CRC Press, Taylor

and Francis Group, Boca Raton, FL.

144

Blackard, W. G. and Nelson, N. C. (1970). Portal and peripheral vein immuno-

reactive insulin concentrations before and after glucose infusion. Diabetes 19: 302-

306.

Blanchette, J. O., Kavimandan, N. and Peppas, N. A. (2004). Principles of

transmucosal delivery of therapeutic agents. Biomedicine and Pharmacotherapy 58:

142-151.

Bogman, K., Zysset, Y., Degen, L., Hopfgartner, G., Gutmann, H., Alsenz, J. and

Drewe, J. (2005). Pglycoprotein and surfactants: effect on intestinal talinolol

absorption. Clinical Pharmacology and Therapeutics 77: 24–32.

Bookbinder, L. H., Hofer, A., Haller, M. F., Zepeda, M. L., Keller, G. A., Lim, J. E.,

Edgington, T. S., Shepard, H. M., Patton, J. S. and Frost, G. I. (2006). A recombinant

human enzyme for enhanced interstitial transport of therapeutics. Journal of

Controlled Release 114: 230-41.

Borchard, G., Luessen, H. L., Verhoef, J. C., Lehr, C. M., de Boer, A. G. and

Junginger, H. E. (1996) The potential of mucoadhesive polymers in enhancing

intestinal peptide drug absorption III: Effects of chitosan-glutamate and carbomer on

epithelial tight junctions in vitro. Journal of Controlled Release 39: 131-138.

Bowe, C. L., Mokhtarzadeh, L., Venkatesan, P., Babu, S., Axelrod, H. R., Sofia, M.

J., Kakarla, R., Chan, T. Y., Kim, J. S., Lee, H. J., Amidon, G. L., Choe, S. Y.,

Walker, S. and Kahne, D. (1997). Design of compounds that increase the absorption

of polar molecules. Proceedings of National Academy of Sciences USA 94: 12218-

12223.

Bowker, S. L., Majumdar, S. R., Veugelers, P. and Johnson, J. A. (2006). Increased

cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or

insulin. Diabetes Care 29: 254-258.

Brayden, D., Creed. E., O’Connell, A., Leipold, H., Argawal, R. and Leone-Bay, A.

(1997). Heparin absorption across the intestine: effects of sodium N-[8-(2-

hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2

monolayers. Pharmaceutical Research 14: 1772-1779.

Bretzel, R. G., Eckhard, M. and Brendel, M. D. (2004). Pancreatic islet and stem cell

transplantation: new strategies in cell therapy of diabetes mellitus. Panminerva

Medica 46: 25-42.

Burdock G. A. (2007). Safety assessment of hydroxypropyl methylcellulose as a food

ingredient. Food and Chemical Toxicology 45: 2341-2351.

Bussemer, T., Otto, I. and Bodmeier, R. (2001). Pulsatile drug-delivery systems.

Critical Reviews in Therapeutic Drug Carrier Systems 18: 433-458.

Camenisch, G., Alsenz, J., van de Waterbeemd, H. and Folkers, G. (1998). Estimation

of permeability by passive diffusion through Caco-2 cell monolayers using the drugs’

145

lipophilicity and molecular weight. European Journal of Pharmaceutical Sciences 6:

317-324.

Campos-Aldrete, M. E. and Villafuerte-Robles, L. (1997). Influence of the viscosity

grade and the particle size of HPMC on metronidazole release from matrix tablets,

European Journal of Pharmaceutics and Biopharmaceutics 43:173-178.

Cappelleri, J. C., Cefalu, W. T., Rosenstock, J., Kourides, I. A. and Gerber, R. A.

(2002). Treatment satisfaction in type 2 diabetes: A comparison between an inhaled

insulin regimen and a subcutaneous insulin regimen. Clinical Therapeutics 24: 552-

564.

Carmel, R. (1994). In vitro studies of gastric juice in patients with food-cobalamin

malabsorption. Digestive Diseases and Sciences 39: 2516-2522.

Ch’ng, H. S., Park, K., Kelly, P. and Robinson, J. R. (1985). Bioadhesive polymers as

platform for oral controlled drug delivery. II Synthesis and evaluation of some

swelling, water insoluble bioadhesive polymers. Journal of Pharmaceutical Sciences

74: 399-404.

Chae, S. Y., Jang, M. -K. and Nah, J. -W. (2005). Influence of molecular weight on

oral absorption of water soluble chitosans. Journal of Controlled Release 102: 383–

394.

Chang, L. L., Stout, L. E., Wong, W. D., Buls, J. G., Rothenberger, D. A., Shier, W.

T., Sorenson, R. L. and Bai, J. P. (1997). Immunohistochemical localization of

insulin-degrading enzyme along the rat intestine, in the human colon adenocarcinoma

cell line (Caco-2), and in human ileum. Journal of Pharmaceutical Sciences 86: 116-

119 .

Chao, A. C., Nguyen, J. V., Broughall, M., Recchia, J., Kensil, C. R., Daddona, P. E.

and Fix, J. A. (1998a) Enhancement of intestinal model compound transport by DS-1,

a modified Quillaia saponin. Journal of Pharmaceutical Sciences 87: 1395-1399.

Chao, A. C., Taylor, M. T., Daddona, P. E., Broughall, M. and Fix, J. A. (1998b).

Molecular weight dependent paracellular transport of fluorescent model compounds

induced by palmitoylcarnitine chloride across the human intestinal epithelial cell line

Caco-2. Journal of Drug Targeting 6:37–43.

Chatterjee, S. and Hadi, A. S. (2006). Regression analysis by example. pp 125-128.

John Wiley and Sons Inc., Hoboken, New Jersey.

Chauvierre, C., Labarre, D., Couvreur, P. and Vauthier, C. (2003). Novel

polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles. Pharmaceutical

Research 20: 1786–1793.

Chelminska-Bertilsson, M., Edebo, A., Thompson, R. A. and Edebo, L. (1995).

Enzymatic hydrolysis of long-chain alkanoylcholines in rat intestinal loops.

Scandinavian Journal of Gastroenterology 30:670–674.

146

Chiarello, K. (2004). Breaking the barrier: advances in transdermal technology.

Pharmaceutical Technology Oct: 46-56.

Chien, Y. W., Su, K. S. E. and Chang, S. (1989). Nasal systemic drug delivery. In:

Chien, Y.W. (ed). Drugs and the pharmaceutical sciences. pp 1-26. Marcel Dekker,

New York.

Chong-Kook, K., Eun-Bin, I., Soo-Jeong, L., Yu-Kyoung, O. and Seok-Kyu, H.

(1994). Development of glucose-triggered pH-sensitive liposomes for a potential

insulin delivery. International Journal of Pharmaceutics 101: 191-197.

Chourasia, M. K. and Jain, S. K. (2003). Pharmaceutical approaches to colon targeted

drug delivery systems. Journal of Pharmacy and Pharmaceutical Sciences 6: 33-66.

Citi, S. (1992). Protein kinase inhibitors prevent junction dissociation induced by low

extracellular calcium in MDCK epithelial cells. Journal of Cell Biology 117: 169-178.

Clausen, A. E. and Bernkop-Schnu rch, A. (2000). In vitro evaluation of permeation-

enhancing effect of thiolated polycarbophil. Journal of Pharmaceutical Sciences 89:

1253–1261.

Clement, S., Still, J. G., Kosutic, G. and Mcallister, R. G. (2002). Oral insulin product

hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose

stabilization effects of HIM2. Diabetes Technology and Therapeutics 4: 459-466.

Collnot, E. M., Baldes, C., Wempe, M. F., Hyatt, J., Navarro, L., Edgar, K. J.,

Schaefer, U. F. and Lehr, C. M. (2006). Influence of vitamin E TPGS poly(ethlyene

glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. Journal

of Controlled Release 111:35–40.

Colthorpe, P., Fair, S. J., Smith, I. J., Wyatt, D. and Taylor, G. (1995). The influence

of regional deposition on the pharmacokinetics of pulmonary-delivered human growth

hormone in rabbits. Pharmaceutical Research 12: 356-359.

Colthorpe, P., Fair, S. J., Taylor, G., Smith, I. J. and Wyatt, D. (1992). The

pharmacokinetics of pulmonarydelivered insulin: a comparison of intratracheal and

aerosol administration to the rabbit. Pharmaceutical Research 9: 764-768.

Currie, C. J., Poole, C. D. and Gale, E. A. (2010). The influence of glucose-lowering

therapies on cancer risk in type 2 diabetes. Diabetologia 52: 1766-1777.

Dallas, T. X. (2008). May, 28. AccessPharma, Newsroom. <http:

//www.accesspharma.com/newsroom/access-pharmaceuticals-presents-new-data-at-

international-symposium-showing-companys-cobalamin-oral-insulin-provides-

substantial-reduction-of-blood-glucose-levels-in-diabetes-model/>. Accessed 2010

May, 20.

Dallas, T. X. (2010). Mar, 11. AccessPharma, Newsroom. <http:

//www.accesspharma.com/newsroom/access-pharmaceuticals-reports-significant-oral-

147

bioavailability-of-cobalamintm-oral-insulin-in-additional-studies/#more-609>.

Accessed 2010 May, 20.

Damge, C., Michel, C., Aprahamian, M. and Couvreur, P. (1988). New approach for

oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug

carrier. Diabetes 37: 246–251.

Damge, C., Michel, C., Aprahamian, M., Couvreur, P. and Devissaguet, J. P. (1990).

Nanocapsules as carriers for oral peptide delivery. Journal of Contolled Release 13:

233–239.

Datar, R. and Rosen, C. (1990). Downstream process economics. In: Asenjo J. A.

(eds). Separation Processes in Biotechnology. pp. 741-793. Marcel Dekker, Inc., New

York and Basel.

DeFronzo, R. A. and Ferrannini, E. (1991). Insulin resistance. A multifaceted

syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and

atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194.

Demina, T., Grozdova, I., Krylova, O., Zhirnov, A., Istratov, V., Frey, H., Kautz, H.

and Melik-Nubarov, N. (2005). Relationship between the structure of amphiphilic

copolymers and their ability to disturb lipid bilayers. Biochemistry 44: 4042-4054.

Desai, M. P., Labhasetwar, V., Amidon, G. L. and Levy, R. J. (1996). Gastrointestinal

uptake of biodegradable microparticles: effect of particle size. Pharmaceutical

Research 13: 1838–1845.

Deutel, B., Greindl, M., Thaurer, M. and Bernkop-Schnurch, A. (2008). Novel insulin

thiomer nanoparticles: in vivo evaluation of an oral drug delivery system.

Biomacromolecules 9: 278–285.

Dew, M. J., Hughes, P. J., Lee, M. G., Evans, B. K. and Rhodes, J. (1982). An oral

preparation to release drugs in the human colon. British Journal of Clinical

Pharmaceutics 14: 405-408.

Di Pierro, M., Lu, R., Uzzau, S., Wang, W., Margaretten, K., Pazzani, C., Maimone,

F. and Fasano, A. (2001) Zonula Occludens toxin structure-function analysis:

identification of the fragment biologically active on tight junctions and of the Zonulin

receptor binding domain. Journal of Biological Chemistry 276:19160–19165.

Diabetology (2010a). Jun, 04. Diabetology, Projects, CapsulinTM

OAD. <http:

//www.diabetology.co.uk/capsulinoad.htm >. Accessed 2010 Jun, 04.

Diabetology (2010b). Jun, 04. Diabetology, Projects, CapsulinTM

OAD. <http:

//www.diabetology.co.uk/capsulinoad.htm >. Accessed 2010 Jun, 04.

Dillen, K., Vandervoort, J., Van den Mooter, G., Verheyden, L. and Ludwig, A.

(2004). Factorial design, physicochemical characterization and activity of

148

ciprofloxacin-PLGA nanoparticles. International Journal of Pharmaceutics 275: 171-

187.

Dixon, J. B., O'Brien, P. E., Playfair, J., Chapman, L., Schachter, L. M., Skinner, S.,

Proietto, J., Bailey, M. and Anderson, M. (2008). Adjustable gastric banding and

conventional therapy for type 2 diabetes: a randomized controlled trial. Journal of

Americal Medical Association 299: 316-323.

Donovan, M. D. and Huang. Y. (1998). Large molecule particulate uptake in the nasal

cavity: The effect of size on nasal absorption. Advance Drug Delivery Reviews 29:

147-155.

Drapeau, G., Petitclerc, E., Toulouse, A. and Marceau, F. (1992). Dissociation of the

antimicrobial activity of bacitracin USP from its renovascular effects. Antimicrobial

Agents and Chemotherapy 36: 955-961.

Duizer, E., Van der Wulp, C., Versantvoort, C. H. M. and Groten, J. P. (1998).

Absorption enhancement, structural changes in tight junctions and cytotoxicity caused

by palmitoyl carnitine in Caco-2 and IEC-18 cells. Journal of Pharmacology and

Experimental Therapeutics 287: 395–402.

Durrer, C., Irache, J. M., Puisieux, F., Duchene, D., Ponchel, G. (1994).

Mucoadhesion of latexes II. Adsorption isotherms and desorption studies.

Pharmaceutical Research 11: 680–683.

Dwivedi, N., Arunagiinathan, M. A., Sharma, S. and Bellare, J. (2010). Silica-coated

liposomes for insulin delivery. Journal of Nanomaterials Article ID 652048. < http:

//downloads.hindawi.com/journals/jnm/2010/652048.pdf>. Accessed 2010 Jun, 04.

Eaton, R. P., Allen, R. C., Schade, D. S., Erickson, K. M. and Standefer, J. (1980).

Prehepatic insulin production in man: kinetic analysis using peripheral connecting

peptide behavior. Journal of Clinical Endocrinological Metababolism 51: 520-528.

Edman, P., Bjork, E. and Ryden, L. (1992). Microspheres as a nasal delivery system

for peptide drugs. Journal of Controlled Release 21: 165-172.

Engel, R. H. and Riggi. S. J. (1969). Intestinal absorption of heparin facilitated by

sulfated or sulfonated surfactants. Journal of Pharmaceutical Sciences 58: 706-710.

Essa, E. A., Bonner, M. C. and Barry, B. W. (2003). Electroporation and

ultradeformable liposomes; human skin barrier repair by phospholipid. Journal of

Controlled Release 92: 163-172.

Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J. and Hardcastle, J. D.

(1988). Measurement of gastrointestinal pH profiles in normal ambulant human

subjects. Gut 29: 1035-1041.

[FAQS] FAQ.org Internet FAQ Archives. (2010a). Jan, 11. Oramed Pharmaceutical

Inc. - Form S-1<http://www.faqs.org/sec-filings/100111/ORAMED-

PHARMACEUTICALS-INC_S-1_FORM2/>. Accessed 2010 Jun, 04.

149

[FAQS] FAQ.org Internet FAQ Archives.. (2010b). Jan, 11. Halozyme Therapeutics

Inc. – Form 8-K - EX-99.1 <http: //www.faqs.org/sec-filings/100111/HALOZYME-

THERAPEUTICS-INC_8-K/a54795exv99w1.htm >. Accessed 2010 Jun, 04.

Fasano, A. (2001). Intestinal Zonulin: open sesame! Gut 49:159–162.

Fasano, A., Uzzau, S., Fiore, C. and Mararetten, K. (1997). The enterotoxic effect of

Zonula Occludens toxin on rabbit small intestine involves the paracellular pathway.

Gastroentrology 112:839–846.

Feger, J., Gil-Falcon, S. and Lamaze, C. (1994). Cell receptors: definition,

mechanisms and regulation of receptor-mediated endocytosis. Cellular and Molecular

Biology. 40: 1039-1061.

Flood, T. (2006). Advances in insulin delivery systems and devices: beyond the vial

and syringe. Insulin.1: 99-108.

Flood, T. M. (2007). Appropriate use of insulin analogs in an increasingly complex

type 2 diabetes mellitus (T2DM) landscape. Journal of Family Practice 56: S1-S12.

Florence, A. T., Hillery, A. M., Hussain, N. and Jani, P. U. (1995). Nanoparticles as

carriers for oral peptide absorption: studies on particle uptake and fate. Journal of

Controlled Release 36: 39–46.

Flory, P. J. (1953). Principle of Polymer Chemistry. pp 541-556. Cornell University

Press, Ithaca, New York.

Foger, F., Hoyer, H., Kafedjiiski, K., Thaurer, M. and Bernkop-Schnurch, A. (2006a).

In vivo comparison of various polymeric and low molecular mass inhibitors of

intestinal P-glycoprotein. Biomaterials 27: 5855–5860.

Foger, F., Schmitz, T. and Bernkop-Schnurch, A. (2006b). In vivo evaluation of an

oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials 27:

4250–4255.

Fonseca, C., Simoes, S. and Gaspar, R. (2002). Paclitaxel-loaded PLGA

nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral

activity. Journal of Controlled Release 83: 273–286.

Forst, T., Pfützner, A., Flacke, F., Krasner, A., Hohberg, C., Tarakc, E., Pichotta, P.,

Forst, S. and Steiner, S. (2010). Postprandial Vascular Effects of VIAject Compared

With Insulin Lispro and Regular Human Insulin in Patients With Type 2 Diabetes.

Diabetes Care 33: 116-120.

Fujii, S., Yokohama, T., Ikegaya, K., Salo, F., Yakoo, N. (1985). Promoting effect of

the new chymotrypsin inhibitor FK-448 on the intestinal absorption of insulin in rats

and dogs. Journal of Pharmacy and Pharmacology 37: 545-549.

150

Galindo-Rodriguez, S. A., Allemann, E., Fessi, H. and Doelker, E. (2005). Polymeric

nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo

studies. Critical Reviews in Therapeutic Drug Carrier Systems 22: 419–464.

Garner, C. W. J. and Behal, F. J. (1974). Human liver aminopeptidase. Role of metal

ions in mechanism of action. Biochemistry 13: 3227–3233.

Geho, W. B., Geho, H. C., Lau, J. R. and Gana, T. J. (2009a). Hepatic-Directed

Vesicle Insulin: A review of formulation development and preclinical evaluation.

Journal of Diabetes Science and Technology 3: 1451-1459.

Geho, B., Lau, J. Rosenberg, L. and Schwartz, S. (2009b). A Single-Blind, Placebo-

Controlled, Food-Dose Timing Trial of Oral HDV-Insulin in Patients with Type 2

Diabetes Mellitus. 69th Scientific Sessions of the American Diabetes Association

(ADA), June 5-9, Morial Convention Center, New Orleans, La.

Germann, U. A., Shlyakhter, D., Mason, V. S., Zelle, R. E., Duffy, J. P., Galullo, V.,

Armistead, D. M., Saunders, J. O., Boger, J. and Harding, M. W. (1997). Cellular and

biochemical characterization of VX-710 as a chemosensitizer: Reversal of P-

glycoprotein-mediated multidrug resistance in vitro. Anticancer Drugs 8:125–140.

Gerrard, G., Payne, E., Baker, R. J., Jones, D. T., Potter, M. and Prentice, H. G.

(2004). Clinical effects and P-glycoprotein inhibition in patients with acute myeloid

leukaemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.

Haematologica 89: 782–790.

Geuze, J. J., Slot, J. W. and Strou, G. J. (1983). Intracellular site of asiologlycoprotein

receptor-ligand uncoupling: double-label immunoelectronmicroscopy during receptor-

mediated endocytosis. Cell 35: 277-287.

Gin, H., Renard, E., Melki, V. and Boivin S. B. Schaepelynck-Belicar, P., Guerci, B.,

Selam, J. L., Brun, J. M., Riveline, J. P., Estour, B., Catargi, B. and EVADIAC Study

Group. (2003). Combined improvements in implantable pump technology and insulin

stability allow safe and effective long term intraperitoneal insulin delivery in type 1

diabetic patients: the EVADIAC experience. Diabetes and Metabolism 29: 602-607.

Gingerich, R. L., Gilbert, W. R., Comens, P. G. and Gavin, J. R. (1987). Identification

and characterization of insulin receptors in basolateral membranes of dog intestinal

mucosa. Diabetes 36: 1124-1129.

Ginsburg, A. and Schachman, H. K. (1960). Studies on the Enzymatic Breakdown of

Proteins I. Action of Chymotrypsin on Insulin. Journal of Biological Chemistry 235:

108-114.

Giovannucci, E. (2001). Insulin, insulin-like growth factors and colon cancer: a

review of the evidence. Journal of Nutrition 131: 3109S-3120S.

Golomb, G., Shaked, I. and Hoffman, A. (1995). Intrauterine administration of

peptide drugs for systemic effect. Advanced Drug Delivery Reviews 17: 179-190.

151

Gordon, G. S., Moses, A. C., Silver, R. D., Flier, J. S. and Carey, M. C. (1985). Nasal

absorption of insulin: Enhancement by hydrophobic bile salts. Proceedings of the

National Academy of Sciences of the USA 82: 7419-7423.

Goriya, Y., Bahoric, A., Marliss, E. B., Zinman, B. and Albisser, A. M. (1980). Blood

glucose control and insulin clearance in unrestrained diabetic dogs portally infused

with a portable insulin delivery system. Diabetologia 19: 452-457.

Goriya, Y., Bahoric, A., Marliss, E. B., Zinman, B. and Albisser, A. M. (1982).

Responses to mixed meals in pancreatectomized dogs deprived of postprandial

insulin. Americal Journal of Physiology 242: E335-E342.

Goss, J. A., Goodpaster, S. E., Brunicardi, F. C., Barth, M. H., Soltes, G. D., Garber,

A. J., Hamilton, D. J., Alejandro, R. and Ricordi, C. (2004). Development of a human

pancreatic islet-transplant program through a collaborative relationship with a remote

islet-isolation center. Transplantation 77: 462-466.

Gotoh, S., Nakamura, R., Nishiyama, M., Fujita, T., Yamamoto, S. and Muranishi, S.

(1995). Does bacitracin have an absorption-enhancing effect in the intestine?

Biological and Pharmaceutical Bulletin 18: 794-796.

Grajower, M. M., Fraser, C. G., Holcombe, J. H., Daugherty, M. L., Harris, W. C., De

Felippis, M. R., Santiago, O. M. and Clark, N. G. (2003). How long should insulin be

used once a vial is started? Diabetes Care 26: 2665-2669.

Greenwood, R. and Al-Achi, A. (1997). Human insulin diffusion profile through a

layer of Caco-2 cells. Drug Development and Industrial Pharmacy 23: 221-224.

Gustafsson, C., Bonferoni, M. C., Carmella, C., Lennholm, H. and Nystrom, C.

(1999). Characterization of particle properties and compaction behaviour of

hydroxypopylmethylcellulose with different degrees of methoxy/hydroxypopyl

substitution. European Journal of Pharmaceutical Sciences 9: 171-184.

Gwinup, G., Elias, A. N. and Domurat, E. S. (1991). Insulin and C-peptide levels

following oral administration of insulin in intestinal-enzyme protected capsules.

General Pharmacology 22: 243-246.

Halban, P. A., Kahn, S. E., Lernmark, A. and Rhodes, C. J. (2001). Gene and cell-

replacement therapy in the treatment of type 1 diabetes: How high must the standards

be set? Diabetes 50: 2181-2191.

Hardy, J. G., Evans, D. F., Zaki, I., Clark, A. G., Tonnesen, H. H., and Gamst, O. N.

(1987). Evaluation of an enteric coated naproxen tablet using gamma scintigraphy and

pH monitoring. International Journal of Pharmaceutics 37: 245-250.

Harrison, L.C., Honeyman, M. C., Steele, C. E., Stone, N. L., Sarugeri, E., Bonifacio,

E., Couper, J. J. and Colman, P. G. (2004). Pancreatic β-Cell function and immune

responses to insulin after administration of intranasal insulin to humans at risk for

type 1 diabetes. Diabetes Care 27: 2348-2355.

152

Hassan, C. M. and Peppas, N. A. (1999). Novel ethylene glycol-containing, pH-

sensitive hydrogels for drug delivery applications: "Molecular Gates" for insulin

delivery. In: Dinh, S. M., DeNuzzio, J. D. and Comfort, A. R. (eds). Intelligent

materials for controlled release. pp 54-69. Americal Chemical Society, USA.

Heinemann, L., Prutzner, A. and Heise, T. (2001). Alternative routes of

administration as an approach to improve insulin therapy: update on dermal, oral,

nasal and pulmonary insulin delivery. Current Pharmaceutical Design 7: 1327-1351.

Henry, R. R. (1996). Glucose control and insulin resistance in non-insulin-dependent

diabetes mellitus. Annals of Internal Medicine 124: 97-103.

Hering, B. G., Kandaswamy, R., Harmon, J. V., Ansite, J. D., Clemmings, S. M.,

Sakai, T., Paraskevas, S., Eckman, P. M., Sageshiva, J., Nakano, M., Sawada, T.,

Matsumoto, I., Zhang, H. J., Sutherland, D. E. and Bluestone, J. A. (2004).

Transplantation of cultured islets from two-layer preserved pancreases in type 1

diabetes with anti-CD3 antibody. American Journal of Transplantation 4: 390-401.

Hilsted, J., Madasbad, S. and Hvidberg, A. (1995). Intranasal insulin therapy: the

clinical realities. Diabetologica 38: 680-684.

Hirai, S., Ikenaga, R., Matsuzawa, T. (1978). Nasal absorption of insulin in dogs.

Diabetes 27: 269-299.

Hochman, J. and Artursson, P. (1994). Mechanism of absorption enhancement and

tight junction regulation. Journal of Controlled Release 29: 253-267.

Hoffman, A. and Ziv, E. (1997). Pharmokinetic Considerations of New Insulin

Formations and Routes of Administration. Clinical Pharmacokinetics 33: 285-301.

Hollander, P. A. (2007). Evolution of a pulmonary insulin delivery system (Exubera)

for patients with diabetes. Medscape General Medicine: 9(1): 45. < http:

//www.ncbi.nlm.nih.gov/pmc/articles/PMC1925008/>. Accessed 2008 Jun, 25.

Hornof, M. D., Kast, C. E. and Bernkop-Schnurch, A. (2003). In vitro evaluation of

the viscoelastic behavior of chitosan –thioglycolic acid conjugates. European Journal

of Pharmaceutics and Biopharmaceutics 55: 185–190.

Hosny, E. A., Al-Marzouki, Z. M., Metwally, M. E., Souaida, M. Y. and Alshaik, A.

R. (2003). Evaluation of efficiency of insulin suppository formulations containing

sodium salicylate or sodium cholate in insulin dependent diabetic patients. Boll Chim

Farm 142: 361-366.

Hosny, E. A., Al-Shora, H. I. and Elmazar. M. M. (2001). Effect of different bile salts

on the relative hypoglycemia of witepsol W35 suppositories containing insulin in

diabetic beagle dogs. Drug Development and Industrial Pharmacy 27: 837-845.

Hosny, E., Al-Shora, H. and Elmazar, M. (2002). Oral delivery of insulin from

enteric-coated capsules containing salicylate: effect on relative hypoglycemia of

diabetic beagle dogs. International Journal of Pharmaceutics 237, 71-76.

153

Hosny, E., el-Ahmady, O., el-Shattawy, H., Nabih A, el-M., el-Damacy, H., Gamal-

el-Deen, S. and el-Kabbany, N. (1994). Effect of sodium salicylate on insulin rectal

absorption in humans. Arzneimittel-Forschung 44: 611-613.

Huang, Y., Leobandung, W., Foss, A. and Peppas, N. A. (2000). Molecular aspects of

muco- and bioadhesion: tethered structures and site-specific surfaces. Journal of

Controlled Release 65: 63-71.

Hugger, E. D., Audus, K. L. and Borchardt, R. T. (2002). Effects of poly(ethylene

glycol) on efflux transporter activity in Caco-2 cell monolayers. Journal of

Pharmaceutical Sciences 91:1980–1990.

Hussain, M. A., Lim, M. S., Raghavan, K. S., Rogers, N. J., Hidalgo, R. and Kettner,

C. A. (1992). A phosphinic acid dipeptide analogue to stabilize peptide drugs during

their intranasal absorption. Pharmaceutical Research 9: 626-628.

Hussain, M. A., Shenvi, A. B., Rowe, S. M. and Shefter, E. (1989). The use of alpha-

aminoboronic acid derivatives to stabilize peptide drugs during their intranasal

absorption. Pharmaceutical Research 6: 186-189.

ICH Q2A (1995). Guideline for Industry: Text on Validation of Analytical

Procedures.<http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryI

nformation/Guidances/ucm073381.pdf> Accessed 2006 Feb, 13.

ICH Q2B (1996). Guidance for Industry: Validation of Analytical Procedures:

Methodology.<http://www.fda.gov/downloads/Regulator%20yInformation/Guidances

/UCM128049.pdf >Accessed 2006 Feb, 13.

Ikesue, K., Kopeckova, P. and Kopecek, J. (1993). Degradation of proteins by guinea

pig intestinal enzymes. International Journal of Pharmaceutics 95:171–179.

Illum. L., Farraj, N. F. and Davis, S. S. (1994a). Chitosan as a novel nasal delivery

system for peptide drugs. Pharmceutical Research 11: 1186–1189.

Illum, L., Farraj, N. F., Fisher, A. N., Gill, I., Miglietta, M., Benedetti, L. M. (1994b).

Hyaluronic acid ester microspheres as a nasal delivery system for insulin. Journal of

Controlled Release 29: 133-141.

Inagaki, M., Sakakura, Y., Itoh, H., Ukai, K. and Miyoshi, Y. (1985). Macromolecular

permeability of the tight junction of the human nasal mucosa. Rhinology 23: 213-221.

In-pharmatechnologist (2003). July, 23. Headlines, Materials and Formulations. <http:

//www.in-pharmatechnologist.com/Materials-Formulation/Emisphere-tech-aids-oral-

protein-delivery> Accessed 2006 Jan, 10

Iwanaga, K., Ono, S., Narioka, K., Morimoto, K., Kakemi, M., Yamashita, S., Nango,

M. and Oku, N. (1997). Oral delivery of insulin by using surface coating liposomes:

Improvement of stability of insulin in GI tract. International Journal of

Pharmaceutics 157: 73-80.

154

Johnson, B. M., Charman, W. N. and Porter, C. J. H. (2002). An in vitro examination

of the impact of polyehtylene glycol 400, pluronic P85 and vitamin E D-a-tocopheryl

polyethylene glycol 1000 succinate on p-glycoprotein efflux and enterocyte-based

metabolism in excised rat intestine. AAPS PharmSci 4: 1–13.

Johnson, F. A., Craig, D. Q. and Mercer, A. D. (1997). Characterization of the block

structure and molecular weight of sodium alginates. Journal of Pharmacy and

Pharmacology 49: 639–643.

Johnson, J. A. and Gale, E. A. (2010). Diabetes, insulin use, and cancer risk: are

observational studies part of the solution-or part of the problem? Diabetes 59: 1129-

1131.

Junginger, H. E. and Verhoef, J. C. (1998). Macromolecules as safe penetration

enhancers for hydrophilic drugs – a fiction? Pharmaceutical Science & Technology

Today 1: 370–376.

Kajii, H., Hore, T., Hayashi, M. and Awazu, S. (1985). Fluorescence study on the

interaction of salicylate with rat small intestinal epithelial cells: Possible mechanism

for the promoting effects of salicylate on drug absorption in vivo. Life Sciences 37:

523-530.

Kast, C. E. and Bernkop-Schnurch, A. (2001). Thiolated polymers-thiomers:

development and in vitro evaluation of chitosan-thioglycolic acid conjugates.

Biomaterials 22: 2345–2352.

Kavimandan, N. J. and Peppas, N. A. (2008). Confocal microscopic analysis of

transport mechanisms of insulin across the cell monolayer. International Journal of

Pharmaceutics 354: 143-148.

Keegan, A. (2007). Exit Exubera. Inhalable insulin is withdrawn due to weak sales.

Diabetes Forecast 60: 19.

Kessler, L., Bucher, P., Milliat-Guittard, L., Benhamou, P. T., Berney, T., Penfornis,

A., Badet, L., Thivolet, C., Bayle, F., Oberholzer, J., Renoult, E., Brun, M. J., Rifle,

G., Atlan, C., Colin, C. and Morel, P. (2004). Influence of islet transportation on

pancreatic islet allotransplantation in type 1 diabetic patients within the Swiss-French

GRAGIL network. Transplantation 77: 1301-1304.

Kessler, L., Tritscaler, S. and Bohbot, A., Sigrist, S., Karsten, V., Boivin, S., Dufour,

P., Belcourt, A. and Pinget, M. (2001). Macrophage activation in type 1 diabetic

patients with catheter obstruction during peritoneal insulin delivery with an

implantable pump. Diabetes Care 24: 302-307.

Keymeulen, B., Ling, Z., Gorus, F. K., Delvaux, G., Bouwens, L., Grupping, A.,

Hendrieckx, C., Pipe leers, M. M., Van, S. C., Salmela, K. and Pipeleers, D. G.

(1998). Implantation of standardized beta-cell grafts in a liver segment of IDDM

155

patients: graft and recipient characteristics in two cases of insulin-independence under

maintenance immunosuppression for prior kidney graft. Diabetologia 41: 452-459.

Khan, M. Z., Prebeg, Z., and Kurjakovic, N. (1999). A pH-dependent colon targeted

oral drug delivery system using methacrylic acid copolymers I. Manipulation of drug

release using Eudragit-R L100-55 and Eudragit_R S100 combinations. Journal of

Controlled Release 58: 215-222.

Kidron, M., Bar-On, H., Berry, E. M. and Ziv, E. (1982). The Absorption Of Insulin

From Various Regions Of The Rat Intestine. Life Science 31: 2837-2841.

Kim, R. B. (2002). Drugs as P-glycoprotein substrates, inhibitors, and inducers. Drug

Metabolism Reviews 34:47–54.

Kim, B. and Peppas, N. A. (2000a). Complexation phenomena in pH-responsive

copolymer networks with pendent saccharides. Macromolecules 35: 9545-9550.

Kim, B. and Peppas, N. A. (2000b). Synthesis and characterization of pH-sensitive

glycopolymers for oral drug delivery systems. Journal of Biomaterials Science.

Polymer Edition 11: 1271-1281.

Kim, B. and Peppas, N. A. (2003). In vitro release behavior and stability of insulin in

complexation hydrogels as oral drug delivery carriers. International Journal of

Pharmaceutics 266: 29-37.

Kimura, T., Sato, K., Sugimoto, K., Tao, R., Murakami, T., Kurosaki, Y. and

Nakayama, T. (1996). Oral administration of insulin as poly(vinyl alcohol)-gel

spheres in diabetic rats. Biological and Pharmaceutical Bulletin 19: 897–900.

Kimura, Y., Aoki, J., Kohno, M., Ooka, H., Tsuruo, T. and Nakanishi, O. (2002). P-

glycoprotein inhibition by the multidrug resistance-reversing agent MS-209 enhances

bioavailability and antitumor efficacy of orally administered paclitaxel. Cancer

Chemotherapy and Pharmacology 49: 322–328.

Kinget, R., Kalala, W., Vervoort, L. and van den Mooter, G. (1998). Colonic drug

delivery. Journal of Drug Targeting 6: 129-149.

Kipnes, M., Dandona, P., Tripathy, D., Still J. G. and Kosutic, G. (2003). Control of

Postprandial Plasma Glucose by an Oral Insulin Product (HIM2) in Patients With

Type 2 Diabetes. Diabetes Care 26: 421-426.

Knipp, G. T., Vander Velde, D. G., Siahaan, T. J., Borchardt, R. T. (1997). The effect

of b-turn structure on the passive diffusion of peptides across Caco-2 cell monolayers.

Pharmaceutical Research 14: 1332-1340.

Korytkowski, M., Niskanen, L. and Asakura, T. (2005). FlexPen: addressing issues of

confidence and convenience in insulin delivery. Clinical Therapeutics 27: S89-S100.

156

Kotze, A. F., Lueßen, H. L., de Leeuw, B. J., de Boer, A. G., Verhoef, J. C. and

Junginger, H. E. (1998). Comparison of the effect of different chitosan salts and N-

trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2).

Journal of Controlled Release 51: 35-46.

Krauland, A. H., Guggi, D. and Bernkop-Schnurch, A. (2004). Oral insulin delivery:

the potential of thiolated chitosan-insulin tablets on non-diabetic rats. Journal of

Controlled Release 95: 547-555.

Kreuter, J. (1991). Peroral administration of nanoparticles. Advanced Drug Delivery

Reviews 7: 71–86.

Kreuter, J., Muller, U. and Munz, K. (1989). Quantitative and microaudiographic

study on mouse intestinal distribution of polycyanoacrylate nanoparticles.

International Journal of Pharmaceutics 55: 39–45.

Kriwet, B. and Kissel, T. (1996). Poly(acrylic acid) microparticles widen intercellular

spaces of caco-2 cell monolayers: an examination by confocal laser scanning

microscopy. European Journal of Pharmacokinetics and Biopharmaceutics 42: 233-

240.

Kuppens, I. E., Bosch, T. M., van Maanen, M. J., Rosing, H., Fitzpatrick, A., Beijnen,

J. H. and Schellens, J. H. (2005). Oral bioavailability of docetaxel in combination

with OC144-093(ONT-093). Cancer Chemotherapy and Pharmacology 55:72–78.

Lamprecht, A., Schafer, U. and Lehr and C. M. (2001). Size dependent bioadhesion of

micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharmaceutical

Research 18: 788–793.

Landsman, M. L. J., Kwant, G., Mook, G. A. and Zijlstra, W. G. (1976). Light

absorbing properties, stability and spectral stabilization of indocyanine green. Journal

of Applied Physiology 40: 575-583.

Langguth, P., Bohner, V., Biber, J. and Merkle, H. P. (1994). Metabolism and

transport of the pentapeptide metkephamid by brush-border membrane vesicles of rat

intestine. Journal of Pharmacy and Pharmacology 46: 34-40.

Lassmann-Vague, V. and Raccah, D. (2006). Alternatives routes of insulin delivery.

Diabetes and Metabolism 32: 513-522.

Lee, J. W., Park, J. H. and Robinson, J. R. (2000). Bioadhesive-based dosage forms:

The next generation. Journal of Pharmaceutical Sciences 89: 850-866.

Lee, V. H. L. (1988). Enzymatic barriers to peptide and protein absorption, CRC

Critical Reviews in Therapeutic Drug Carrier Systems 5: 69-97.

Lee, V. H. L. and Yamamoto, A. (1990). Penetration and enzymatic barriers to

peptide and protein absorption. Advance Drug Delivery Reviews 4: 171-207.

157

Lee, V. H. L., Yamamoto, A. and Kompella, U. B. (1991). Mucosal penetration

enhancers for facilitation of peptide and protein drug absorption. Critical Reviews in

Therapeutic Drug Carrier Systems 8: 91-192.

Lee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J. D. and Unger, R. H.

(1994). Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes

mellitus of obese rats: Impairment in adipocyte-beta-cell relationships. Proceedings of

the National Academy of Sciences of the USA 91: 10878-10882.

Lehr, C. -M., Bouwstra, J. A., Schacht, E. H. and Junginger, H. E. (1992). In vitro

evaluation of mucoadhesive properties of chitosan and some other natural polymers.

International Journal of Pharmaceutics 78: 43–48.

Leo, E., Brina, B., Forni, F. and Vandelli, M. A. (2004). In vitro evaluation of PLA

nanoparticles containing alipophilic drug in water-soluble or insoluble form.

International Journal of Pharmaceutics 278: 133–141.

Leone-Bay, A., Ho, K., Agarwal, R., Baughman, R. A., Chaudhary, K., DeMorin, F. ,

Genoble, L., McInnes, C., Lercara, C., Milstein, S., O'Toole,. D., Sarubbi, D.,

Variano, B., and. Paton, D. R. (1996a). 4-(4-((2-

Hydroxybenzoyl)amino)phenyl)butyric acid as a novel oral delivery agent for

recombinant human growth hormone. Journal of Medicinal Chemistry 39: 2571-2578.

Leone-Bay, A., Leipold, H., Paton, D. R., Milstein, S. J. and Baughman, R. A.

(1996b). Oral delivery of rhGH: Preliminary mechanistic considerations. Drug News

Perspective 9: 586-590.

Leone-Bay, A., Paton, D. R., Freeman, J., Lercara, C., O'Toole, D., Gschneidner, D.,

Wang, E., Harris, E., Rosado, C., Rivera, T., De Vincent, A., Tai, M., Mercogliano,

F., Agarwal, R., Leipold, H., Baughman, R. A. (1998a). Synthesis and evaluation of

compounds that facilitate the gastrointestinal absorption of heparin. Journal of

Medicinal Chemistry 41: 1163-1171.

Leone-Bay, A., Paton, D., Variano, B., Leipold, H., Rivera, T., Miura-Fraboni, J.,

Baughman, R. A. and Santiago, N. (1998b). Acylated non-a-amino acids as novel

agents for the oral delivery of heparin sodium, USP. Journal of Controlled Release

50: 41-49.

Leoni, L. and Desai, T. A. (2004). Micromachined biocapsules for cell-based sensing

and delivery. Advanced Drug Delivery Reviews 56: 211-229.

Leu, B. L. and Huang, J. D. (1995). Inhibition of intestinal Pglycoprotein and effects

on etoposide absorption. Cancer Chemotherapy and Pharmacology 35: 432–436.

Lin, Y. H., Mi, F. L., Chen, C. T., Chang, W. C., Peng, S. F., Liang, H. F., and Sung,

H. W. (2007a). Preparation and characterization of nanoparticles shelled with chitosan

for oral insulin delivery. Biomacromolecules 8: 146–152.

Lin, Y., Shen, Q., Katsumi, H., Okada, N., Fujita, T., Jiang, X. and Yamamoto, A.

(2007b). Effects of Labrasol and Other Pharmaceutical Excipients on the Intestinal

158

Transport and Absorption of Rhodamine123, a P-Glycoprotein Substrate, in Rats.

Biological and Pharmaceutical Bulletin 30: 1301–1307.

Lindmark, T., Kimura, Y. and Artursson, P. (1998). Absorption enhancement through

intracellular regulation of tight junction permeability by medium chain fatty acids in

Caco-2 cells. Journal of Pharmacology and Experimental Therapeutics. 284: 362-

369.

Lindmark, T., Nikkila, T. and Artursson, P. (1995). Mechanisms of absorption

enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell

monolayers. Journal of Pharmacology and Experimental Therapeutics 275: 958-964.

Lindmark, T., Schipper, N., Lazorova, L., de Boer, A. G. and Artursson, P. (1997).

Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium

caprate: assessment of molecular weight dependence and demonstration of transport

routes. Journal of Drug Targeting 5: 215-223.

Liu, C., Wu, J., Shi, B., Zhang, Y., Gao, T. and Pei, Y. (2006). Enhancing the

bioavailability of cyclosporine a using solid dispersion containing polyoxyethylene

(40) stearate. Drug Development and Industrial Pharmacy 32:115–123.

Lo, Y. L. (2003). Relationships between the hydrophilic–lipophilic balance values of

pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2

cells and rat intestines. Journal of Controlled Release 90: 37–48.

Lohikangas, L., Wilen, M., Einarsson, M. and Artursson, P. (1994). Effects of a new

lipid-based drug delivery system on the absorption of low molecular weight heparin

(Fragmin) through monolayers of human intestinal epithelial Caco-2 cells and after

rectal administration to rabbits. European Journal of Pharmaceutical Sciences 1:

297–305.

Lougheed, W. D., Fischer, U., Perlman, K. and Albisser, A. M. (1981). A physio-

logical solvent for crystalline insulin. Diabetologia 20: 51-53.

Lowman, A. M. and Peppas, N. A. (1999). Solute transport analysis in pH-responsive,

complexing hydrogels of poly(methacrylic acid-g-ethylene glycol). Journal of

Biomaterials Science. Polymer Edition 10: 999-1009.

Luessen, H. L., Bohner, V., Perard, D., Langguth, P., Verhoef, J. C., de Boer, A. G.,

Merkle, H. P. and Junginger, H. E. (1996). Mucoadhesive polymers in peroral peptide

drug delivery.V. Effect of poly(acrylates) on the enzymatic degradation of peptide

drugs by intestinal brush border membrane vesicles. International Journal of

Pharmaceutics 141: 39-52.

Luzio, S. D., Dunseath, G., Lockett, A., Broke-Smith, T. P., New, R. R. and Owens,

D. R. (2009). The glucose lowering effect of an oral insulin (Capsulin) during an

isoglycaemic clamp study in persons with type 2 diabetes. Diabetes, Obesity and

Metabolism 12: 82-87.

159

Ma, X. Y., Pan, G. M., Lu, Z., Hu, J. S., Bei, J. Z., Jia, J. H. and Wang, S. G. (2000).

Preliminary study of oral polylactide microencapsulated insulin in vitro and in vivo.

Diabetes, Obesity and Metabolism 2: 243-250.

Madsen, F. and Peppas, N. A. (1999). Complexation graft copolymer networks:

swelling properties. Calcium binding, and proteolytic enzyme inhibition. Biomaterials

20: 1701-1708.

Maggio, E. T. (2005). Recent developments in intranasal drug delivery technology are

creating new vistas for peptide and protein therapeutics. Drug Deliv Comp Report,

Spring=Summer 34: 37. (Origianl not seen. Cited by Pillion, D. J., Arnold, J. J. and

Meezan, E. 2006. Nasal delivery of peptide drugs. In:Touitou, E. and Barry, B. W.

(eds). Enhancement in Drug Delivery. pp. 373-388. CRC Press, Taylor and Francis

Group, Boca Raton, FL.)

Mahkam, M. (2010). Starch-based polymeric carriers for oral-insulin delivery.

Journal of Biomedical Materials Research A 92: 1392-1397.

Majumdar, S., Duvvuri, S. and Mitra, A. K. (2004). Membrane transporter/ receptor

targeted prodrug design: strategies for human and veterinary drug development.

Advanced Drug Delivery Reviews 56: 1437-1452.

Malingre, M. M., Ten Bokkel Huinink, W. W., Mackay, M., Schellens, J. H. and

Beijnen, J. H. (2001). Pharmacokinetics of oral cyclosporin A when co-administered

to enhance the absorption of orally administered docetaxel. European Journal of

Clinical Pharmacology 57: 305–307.

Mansell, P. (2008). Mar, 11. Headlines, Materials and Formulation. <http: //www.in-

pharmatechnologist.com/Materials-Formulation/Lilly-declines-to-inhale-with-AIR-

Insulin-programme> Accessed 2009 Feb, 10.

Marcus, A. (2008). Diabetes Care – Insulin Delivery in a Changing World. Medscape

Journal of Medicine 10: 120.

Mathieu, C. and Gale, E. A. (2008). Inhaled insulin: gone with the wind?

Diabetologia 51: 1-5.

Matter, K. and Balda, M. S. (2003). Functional analysis of tight junctions. Methods

30: 228-234.

McCaffrey, G. and Jamieson, J. C. (1993). Evidence for the role of a cathepsin D-like

activity in the release of gal beta 1-4 glnac alpha 2-6 sialyltransferase from rat and

mouse liver in wholecell systems. Comparative Biochemistry and Physiology Part C

104: 91-94.

McClellan, J. B. J. and Garner, C. W. (1980). Purification and properties of human

intestine alanine aminopeptidase. Biochimica et Biophysica Acta 613:160–167.

160

McConnell, R. M., Frizell, D., Evans, A. C. A., Jones, W. and Cagle, C. (1991). New

pepstatin analogues: synthesis and pepsin inhibition. Journal of Medicinal Chemistry

34: 2298-2300.

Medical News Today (2007). Nov, 20. Diabetes news. <http:

//www.medicalnewstoday.com/articles/89337.php>. Accessed 2010 Jun, 04.

Merkle, H. P. and Wolany, G. (1992). Buccal delivery for peptide drugs. Journal of

Controlled Release 21: 155-164.

Mesiha, M. and Sidhom, M. (1995). Increased oral absorption enhancement of

insulin by medium viscosity hydroxypropyl cellulose. International Journal of

Pharmaceutics 114: 137-140.

Mi, F. L., Wu, Y. Y., Lin, Y. H., Sonaje, K., Ho, Y. C., Chen, C. T., Juang, J. H. and

Sung, H. W. (2008). Oral delivery of peptide drugs using nanoparticles selfassembled

by poly(gamma-glutamic acid) and a chitosan derivative functionalized by

trimethylation. Bioconjugate Chemistry 19: 1248–1255.

Middleton, D. L., Leung, S. S. and Robinson, J. R. (1990). Ocular Bioadhesive

Delivery Systems. In: Lenaerts, V. and Gurny, R. (eds). Bioadhesive Drug Delivery

Systems. pp 189-192. CRC Press, Boca Raton, FL.

Miller, N. S., Chittchang, M. and Johnston, T. P. (2005). The use of mucoadhesive

polymers in buccal drug delivery. Advanced Drug Delivery Reviews 57: 1666- 1691.

Milstein, S. J., Leipold, H., Sarubbi, D., Leone-Bay, A., Mlynek, G. M., Robinson, J.

R., Kasimova, M. and Freire, E. (1998). Partially unfolded proteins efficiently

penetrate cell membranes - implications for oral drug delivery. Journal of Controlled

Release 53: 259-267.

Mizuno, A., Ueda, M. and Kawanishi, G. (1992). Effects of salicylate and other

enhancers on rectal absorption of erythropoietin in rats. Journal of Pharmacy and

Pharmacology 44: 570-573.

Morgan, R. and Huntzicker, M. A. (1996). Delivery of systemic regular insulin via the

ocular route in dogs. Journal of Pharmacy and Pharmacology 12: 516-526.

Morimoto, K., Takeeda, T., and Nakamoto, Y. (1982). Effective vaginal absorption of

insulin in diabetic rats and rabbits using polyacrylic acid aqueous gel bases.

International Journal of Pharmaceutics 12: 107-111.

Morimoto, K., Yamaguchi, H., Iwakura, Y., Morisaka, K., Ohashi, Y. and Nakai, Y.

(1991). Effects of viscous hyaluronate-sodium solutions on the nasal absorption of

vasopressin and an analogue. Pharmaceutical Research. 8: 471-474.

Morishita, M., Goto, T., Peppas, N. A., Joseph, J. I., Torjman, M. C., Munsick, C.,

Nakamura, K., Yamagata, T., Takayama, K. and Lowman, A. M. (2004). Mucosal

insulin delivery systems based on complexation polymer hydrogels: Effect of particle

size on insulin enteral absorption. Journal of Controlled Release 97: 115– 124.

161

Morishita, M., Kajita, M., Suzuki, A., Takayama, K., Chiba, K., Tokiwa, S. and

Nagai, T. (2000). The dose-related hypoglycemic effects of insulin emulsions

incorporating highly purified EPA and DHA. International Journal of Pharmaceutics

201: 175-185.

Morishita, M., Matsuzawa, A., Takayama, K., Isowa, K. and Nagai, T. (1998).

Improving insulin enteral absorption using water-in-oil-in-water emulsion.

International Journal of Pharmaceutics 172: 189-198.

Mostov, K. and Simister, N. (1985). Transcytosis. Cell 43: 389-390.

Nakamura, K., Muray, R. J., Joseph, J. I., Peppas, N. A., Morishita, M. and Lowman,

A. M. (2004). Oral insulin delivery using P(MAA-g-EG) hydrogels: effects of

network morphology on insulin delivery characteristics. Journal of Controlled

Release 95: 589-599.

Nakanishi, K., Ogata, A., Masada, M. and Nadai, T. (1984). Effect of nonsteroidal

anti-inflammatory drugs on the permeability of the rectal mucosa. Chemical and

Pharmaceutical Bulletin 32: 1956-1966.

Nakanishi, K., Masada, M. and Nadai, T. (1986). Effect of nonsteroidal anti-

inflammatory drugs on the absorption of macromolecular drugs in rat rectum.

Chemical and Pharmaceutical Bulletin 34: 2628-2631.

Nanji, S. A. and Shapiro, A. M. (2004). Islet transplantation in patients with diabetes

mellitus: choice of immunosuppression. Biodrugs 18: 315-328.

Napoli, N., Palermo, A., Lauria, A., Beretta, G., Manfrini, S. and Pozzilli, P. (2009).

Treatment of impaired glucose tolerance with buccal spray insulin: a novel approach.

International Diabetes Federation (IDF) 20th World Diabetes Congress. Poster

discussion D-0965 (Abstr). Montreal.

Navas-Acien, A., Silbergeld, E. K., Pastor-Barriuso, R. and Guallar, E. (2008)

Exposure and prevalence of type 2 diabetes in US adults. Journal of Americal

Medical Association 300: 814-822.

Nealon A. (2008). Pharmaceutical Business Review. <http:

//www.novonordisk.com/include/asp/exe_news_attachment.pdf?sAttachmentGUID=1

531cc83-f75c-4368-995e-f0667112304f>(Original not seen. Cited by Marcus, A.

2008 Medscape Journal of Medicine 10(5): 120. <http:

//www.ncbi.nlm.nih.gov/pmc/articles/PMC2438492/>). Accessed 2009 Jul, 28.

Ning, M., Guo, Y., Pan, H., Yu, H. and Gu, Z. (2005). Niosomes with sorbitan

monoester as a carrier for vaginal delivery of insulin: studies in rats. Drug Delivery

12: 399-407.

Nishihata, T., Kamada, A., Sakai, K., Yagi, T.,Kawamori, R. and Shichiri, M. (1989).

Effectiveness of insulin suppositories in diabetic patients. Journal of Pharmacy and

Pharmacology 4: 799-801.

162

Nishihata, T., Kim, S., Liversidge, G. G. and Higuchi, T. (1986). Rectal absorption

and lymphatic uptake of Ara-C in rats. International Journal of Pharmaceutics 31:

185-191.

Nishihata, T., Lee, C. -S ., Yamamoto, M., Rytting, J. H. and Higuchi, T. (1984). The

effects of salicylate on the rectal absorption of phenylalanine and some peptides, and

the effects of these peptides on the rectal absorption of cefoxitin and cefmetazole.

Journal of Pharmaceutical Sciences 73: 1326-1328.

Nishihata, T., Rytting, J. H. and Higuchi, T. (1981a). Effects of salicylate on rectal

absorption of theophylline. Journal of Pharmaceutical Sciences 70: 71-75.

Nishihata, T., Rytting, J. H., Higuchi, T. and Caldwell, L. (1981b). Enhanced rectal

absorption of insulin and heparin in rats in the presence of non-surfactant adjuvants.

Journal of Pharmacy and Pharmacology 33: 334-335.

Nishihata, T., Rytting, J. H. and Higuchi, T. (1982). Effect of salicylate on the rectal

absorption of lidocaine, levodopa, and cefmetazole in rats. Journal of Pharmaceutical

Sciences 71: 869-872.

Nishihata, T., Rytting, J. H., Kamada, A., Higuchi, T., Routh, M. and Caldwell, L.

(1983). Enhancement of rectal absorption of insulin using salicylates in dogs. Journal

of Pharmacy and Pharmacology 35: 148-151.

Noach, A. B. J., Kurosaki, Y., Blom-Roosemalen, M. C. M., de Boer, A. G., Breimer,

D. D. (1993). Cellpolarity dependent effect of chelation on the paracellular

permeability of confluent Caco-2 cell monolayers. International Journal of

Pharmaceutics 90: 229–237.

Nomura, M., Kubota, M. A., Sekiya, M., Hoshiyama, S., Imano, E., Matushima, I.,

Ishimoto, I., Kawamori, R. and Kamada, T. (1990). Insulin absorption from

conjunctiva studied in normal and diabetic dogs. Journal of Pharmacy and

Pharmacology 42: 292-294.

Okagawa, T., Fujita, T., Murakami, M., Yamamoto, A., Shimura, T., Tabata, S.,

Kondo, S. and Muranishi, S. (1994). Susceptibility of ebiratide to proteolysis in rat

intestinal fluid and homogenates and its protection by various protease inhibitors. Life

Sciences 55: 677-683.

Onuki, Y., Morishita, M., Takayama, K., Tokiwa, S., Chiba, Y., Isowa, K. and Nagai,

T. (2000). In vivo effects of highly purified docosahexaenoic acid on rectal insulin

absorption. International Journal of Pharmaceutics 198: 147-156.

Pan, Y., Li, Y. J., Zhao, H. Y., Zheng, J. M., Xu, H., Wei, G., Hao, J. S. and Cui, F.

D. (2002). Bioadhesive polysaccharide in protein delivery system: chitosan

nanoparticles improve the intestinal absorption of insulin in vivo. International

Journal of Pharmaceutics 249: 139-147.

163

Pardakhty, A., Varshosaz, J., and Rouholamini, A. 2007. In vitro study of

polyoxyethylene alkyl ether niosomes for delivery of insulin. International Journal of

Pharmaceutics 328: 130-141.

Park, H., Amiji, M. and Park, K. (1989). Mucoadhesive hydrogels effective at neutral

pH. Proceedings of the International Symposium on Controlled Release of Bioactive

Materials 16: 217-218.

Park, K., Ch’ng, H. S. and Robinson, J. R. (1984). Alternative approaches to oral-

controlled drug delivery: bioadhesive and in situ systems. Anderson, J. M. and Kim,

S. W. (eds) In: Recent advances in Drug Deliverty System. pp 163. Plenum Press,

New York.

Park, K. and Robinson, J. R. (1984). Bioadhesive polymers as platforms for oral

controlled drug delivery; methods to study bioadhesion. International Journal of

Pharmaceutics 19: 107-127.

Patel, V. F. and Patel, N. M. (2007). Statistical Evaluation of Influence of Viscosity

and Content of Polymer on Dipyridamole Release From Floating Matrix Tablets: A

Technical Note. AAPS PharmSciTech 8: Article 69, E1-E5.

Patton, J. S. (1996). Mechanisms of macromolecule absorption by the lungs.

Advanced Drug Delivery Reviews 19: 3-36.

Peppas, N. A. and Buri, P. A. (1985). Surface, interfacial and molecular aspects of

polymer bioadhesion on soft tissues. Journal of Controlled Release 2: 257-275.

Peppas, N. A., Bures, P., Leobandung, W. and Ichikawa, H. (2000). Hydrogels in

pharmaceutical formulations. European Journal of Pharmaceutics and

Biopharmaceutics 50: 27-46.

Pickup, J. C. (2003). Alternative forms of insulin delivery. In: Pickup, J. C. and

Williams, G. (eds). Textbook of Diabetes, 3rd

ed. pp 44.1-44.15. Oxford: Blackwell

Science.

Pillion, D. J., Ganapathy, V. and Leibach, F. H. (1985). Identification of insulin

receptors on the mucosal surface of colon epithelial cells. Journal of Biological

Chemistry 260: 5244-5247.

Plumpton, C., Kalinka, S., Martin, R. C., Horton, J. K. and Davenport, A. P. (1994).

Effects of phosphoramidon and pepstatin A on the secretion of endothelin-1 and big

endothelin-1 by human umbilical vein endothelial cells - measurement by two-site

enzyme-linked immunosorbent assay. Clinical Science 87: 245-251.

Ponchel, G. and Irache, J. (1998). Specific and non-specific bioadhesive particulate

systems for oral delivery to the gastrointestinal tract. Advnced Drug Delivery Reviews

34: 191–219.

164

Portero, A., Osorio, D. T., Alonso, M. J. and López, C. R. (2007). Development of

chitosan sponges for buccal administration of insulin. Carbohydrate Polymers 68:

617-625.

Prasad, R. (2006). Apr, 06. Biocon, News. <http:

//www.biocon.com/biocon_press_news_details.asp?subLink=news&Fileid=211>.

Accessed 2008 Apr, 25.

Prausnitz, M. R., Bose, V. G., Langer, R. and Weaver, J. C. (1993). Electroporation

of mammalian skin: A mechanism to enhance transdermal drug delivery. Proceedings

of National Academy of Sciences USA 90: 10504-10508.

Raehs, S. C., Sandow, J., Wirth, K. and Merkle, H. P. (1988). The adjuvant effect of

bacitracin on nasal absorption of gonadorelin and buserelin in rats. Pharmaceutical

Research 5: 689-693.

Ramirez-Campos, M. and Villafuerte-Robles, L. (2004). Effect of Formulation

Variables on Verapamil Hydrochloride Release from Hydrated HPMC Matrices.

Revista de la Sociedad Química de Mexico 48: 326-331.

Rawat, M., Singh, D., Saraf, S. and Saraf, S. (2006). Nanocarriers: promising vehicle

for bioactive drugs. Biological and Pharmaceutical Bulletin 29: 1790–1798.

Reaven, G. M. (1988). Banting lecture 1988. Role of insulin resistance in human

disease. Diabetes 37: 1595-1607.

Reaven, G. M. (1994). Syndrome X: 6 years later. Journal of Internal Medicine

736(Suppl.): 13-22.

Renard, E., Costalet, G. and Bringer J. (2002). De la pompe externe á la pompe

implantable, la fermeture de la boucle est-elle possible ? Diabetes and Metabolism 28:

19-25.

Reseland, J. E., Holm, H., Jacobsen, M. B., Jenssen, T. G. and Hanssen, L. E. (1996).

Proteinase inhibitors induce selective stimulation of human trypsin and chymotrypsin

secretion. Journal of Nutrition 126: 634-642.

Richardson, D. W. and Robinson, A. G. (1985). Desmopressin. Annals of Internal

Medicine 103: 228-239.

Richardson, J. L., and Armstrong. T. I. (1999). Vaginal delivery of calcitonin by

hyaluronic acid formulations. In: Mathiowitz, E. Chickering, D. E., and Lehr, C. M.

(eds). Bioadhesive drug delivery systems: Fundamentals, novel approaches, and

development. pp. 45-86. Basel: Marcel Dekker, New York.

Ridley, D., Wilson, C. G., Washington, N., Perkins, A. C., Wastie, M., Ponchel, G.,

Duchene D. and and Blattmann, A. (1995). The effect of posture on the nasal

clearance of starch microspheres. STP Pharma Sciences 5: 442-446.

165

Rivera, T. M., Leone-Bay, A., Paton, D. R., Leipold, H. and Baughman, R. A. (1997)

Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl)

amino]caprylate: pharmacological considerations. Pharmaceutical Research 14:

1830-1834.

Robertson, K. E., Glazer, N. B. and Campbell, R. K. (2000). The latest developments

in insulin injection devices. The Diabetes Educator 26:135-152.

Robinson, D. N. and Peppas, N. A. (2002). Preparation and characterization of pH-

responsive poly(methacrylic acid-g-ethylene glycol) nanospheres. Macromolecules

35: 3668-3674.

Rochira, M., Rochira, M., Miglietta, M. R., Richardson, J. L., Ferrari, L., Beccaro, M.

and Benedetti, L. (1996). Novel vaginal delivery systems for calcitonin. II.

Preparation and characterization of HYAFF microspheres containing calcitonin.

International Journal of Pharmaceutics 144: 19-26.

Rojanasakul, Y., Wang, L., Bhat, M., Glover, D. D., Malanga, C. J. and Ma, J. K. H.

(1992). The Transport Barrier of Epithelia: A Comparative Study on Membrane

Permeability and Charge Selectivity in the Rabbit. Pharmaceutical Research 9: 1029-

1034.

Rubinstein, A. (1995). Approaches and opportunities in colon-specific drug delivery.

Critical Reviews in Therapeutic Drug Carrier Systems 12: 101-149.

Rubinstein, A., Tirosh, B., Baluom, M., Nassar, T., David, A., Radai, R., Irit-Kabir, I.

and Friedman, M., (1997). The rational for peptide drug delivery to the colon and the

potential of polymeric carriers as effective tools. Journal of Controlled Release 46:

59-73.

Ruige, J. B., Assendelft, W. J., Dekker, J. M., Kostense, P. J., Heine, R. J. and Bouter,

L. M. (1998). Insulin and risk of cardiovascular disease: a meta-analysis. Circulation

97: 996-1001.

Russell-Jones, G. J. (2001). The potential use of receptor-mediated endocytosis for

oral drug delivery. Advanced Drug Delivery Reviews 46: 59-73.

Ryan, E. A., Lakey, J. R., Paty, B. W., Imes, S., Korbutt, G. S., Kneteman, N. M.,

Bigam, D., Rajotte, R. V. and Shapiro, A. M. (2002). Successful islet transplantation:

continued insulin reserve provides long-term glycemic control. Diabetes 51: 2148-

2157.

Ryan, E. A., Shandro, T., Green, K., Paty, B. W., Senior, P. A., Bigam, D., Shapiro,

A. M. and Vantyghem, M. C. (2004). Assessment of the severity of hypoglycemia and

glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes

53: 955-962.

166

Saffran, M., Bedra, C., Kumar, G. S. and Neckers, D. C. (1988). Vasopressin: a model

for the study of effects of additives on the oral and rectal administration of peptide

drugs. Journal of Pharmaceutical Sciences 77: 33-38.

Sakai, K., Kutsuna, T. M., Nishino, T., Fujihara, Y. and Yata, N. (1986) Contribution

of calcium ion sequestration by polyoxyethylated nonionic surfactants to the enhanced

colonic absorption of p-aminobenzoic acid. Journal of Pharmaceutical Sciences 75:

387-390.

Sakai, M., Imai, T., Ohtake, H. and Otagiri, M. (1998). Cytotoxicity of absorption

enhancers in Caco-2 cell monolayers. Journal of Pharmacy and Pharmacology 50:

1101-1108.

Sakai, M., Imai, T., Ohtake, H., Azuma, H. and Otagiri, M. (1997). Effects of

absorption enhancers on the transport of model compounds in Caco-2 cell

monolayers: assessment by confocal laser scanning microscopy. Journal of

Pharmaceutical Sciences 86: 779-785.

Sakkinen, M., Tuononen, T., Jürjenson, H., Veski, P. and Marvola, M. (2003).

Evaluation of microcrystalline chitosans for gastro-retentive drug delivery. European

Journal of Pharmaceutical Sciences 19: 345-353.

Salzman, A. L., Menconi, M. J., Unno, N., Ezzell, R. M., Casey, D. M., Gonzalez, P.

K. and Fink, M. P. (1995). Nitric oxide dilates tight junctions and depletes ATP in

cultured Caco-2BBe intestinal epithelial monolayers. American Journal of Physiology

268: G361-G373.

Sangadala, S., Walters, F. S., English, L. H. and Adang, M. J. (1994). A mixture of

Manduca sexta aminopeptidase and phosphatase enhances Bacillus thuringiensis

insecticidal CryIA(c) toxin binding and 86Rb(+)-K+ efflux in vitro. Journal of

Biological Chemistry 269: 10088-10092.

Sanger, F. and Thompson, E. O. P. (1953). The amino-acid sequence in the glycyl

chain of insulin.2. The investigations of peptides from enzymic hydrolysates.

Biochemical. Journal 53: 366-374.

Sayani, A. P. and Chien. Y. W. (1996). Systemic delivery of peptides and proteins

across absorptive mucosae. Critical Reviews in Therapeutic Drug Carrier Systems 13:

85-184.

Schacht, E., Gevaert, A., Kenawy, E. R., Molly, K., Verstraete, W., Adriaensens, P.,

Carleer, R. and Gelan, J. (1996). Polymers for colon specific drug delivery. Journal of

Controlled Release 39: 327-338.

Schilling, R. J. and Mitra, A. K. (1990). Intestinal mucosal transport of insulin.

International Journal of Pharmaceutics 62: 53-64.

Schilling, R. J. and Mitra, A. K. (1991). Degradation of Insulin by Trypsin and α-

Chymotrypsin. Pharmaceutical Research 8: 721-727.

167

Schipper, N. G. M., Romeijn, S. G., Verhoef, J. C. and Merkus, F. W. H. M. (1993).

Nasal insulin delivery with dimethyl-β-cyclodextrin as an absorption enhancer in

rabbits-powder more effective than liquid formulations. Pharmaceutical Research 10:

682-686.

Scott, M. J., Huckaby, C. S., Kato, I., Kohr, W. J., Laskowski, M. J., Tsai, M. J. and

O’Malley, B. W. (1987). Ovoinhibitor introns specify functional domains as in the

related and linked ovomucoid gene. Journal of Biological Chemistry 262: 5899-5907.

Sechter, I., Touitou, E. and Donbrow. M. (1989). The influence of a non-ionic

surfactant on rectal absorption of virus particles. Archives of Virology 106: 141-143.

Sen, A., Daly, M. E. and Hui, S. W. (2002a). Transdermal insulin delivery using lipid

enhanced electroporation. Biochimica et Biophysica Acta 1564: 5-8.

Sen, A., Zhao, Y. and Hui, S. W. (2002b). Saturated anionic phospholipids enhance

transdermal transport by electroporation. Biophysics Journal 83: 2064-2073.

Shen, Q., Lin, Y., Handa T., Doi, M., Sugie, M., Wakayama, K., Okada, N., Fujita, T.,

Yamamoto, A. (2006). Modulation of intestinal P-glycoprotein function by

polyethylene glycols and their derivatives by in vitro transport and in situ absorption

studies. International Journal of Pharmaceutics 313: 49–56.

Shen, W. -C. and Ryser, H. (1981). Poly(L-lysine) has different membrane transport

and drug-carrier properties when complexed with heparin. Proceedings of National

Academy of Sciences USA 78: 7589-7593.

Shimazaki, T., Tomita, M., Sadahiro, S., Hayashi, M. and Awazu, S. (1998).

Absorption-enhancing effects of sodium caprate and palmitoyl carnitine in rat and

human colons. Digestive Diseases and Sciences 43: 641-645.

Shishko, P. I., Kovalev, P. A., Goncharov, V. G. and Zajarny, I. U. (1992).

Comparison of peripheral and portal (via the umbilical vein) routes of insulin infusion

in IDDM patients. Diabetes 41: 1042-1049.

Shono, Y., Nishihara, H., Matsuda, Y., Furukawa, S., Okada, N., Fujita, T. and

Yamamoto, A. (2004). Modulation of intestinal P- glycoprotein function by

cremophor EL and other surfactants by an in vitro diffusion chamber method using

the isolated rat intestinal membranes. Journal of Pharmaceutical Sciences 93: 877–

885.

Simons, K. and Fuller, S. D. (1985). Cell surface polarity in epithelia. Annual Reviews

in Cell Biology 1: 243-248.

Simovic, S., Heard, P., Hui, H., Song, Y., Peddie, F., Davey, A. K., Lewis, A., Rades,

T. and Prestidge, C. A. (2009). Dry hybrid lipid-silica microcapsules engineered from

submicron lipid droplets and nanoparticles as a novel delivery system for poorly

soluble drugs. Molecular Pharmaceutics 6: 861-872.

168

Singh, J., Gupta, S. and Kaur, H. (2011). Prediction of in vitro drug release

mechanisms from extended release matrix tablets using SSR/R2 technique. Trends in

Applied Sciences Research 6: 400-409.

Sinha, V. R., Kumria, R. (2001). Colonic drug delivery: prodrug approach.

Pharmaceutical Research 18: 557-564.

Sircar, A. R. (2002). Alternative routes of insulin delivery. International Journal of

Diabetes in Developing Countries 22: 119-121.

Skyler, J. S., Cefalu, W. T., Kourides, I. A., Landschulz, W. H., Balagtas, C. C.,

Cheng, S. L. and Gelfand, R. A. (2001). Efficacy of inhaled human insulin in type 1

diabetes mellitus: a randomised proof-of-concept study. Lancet 357: 331-335.

Skyler, J. S., Jovanovic, L., Klioze, S., Reis, J. and Duggan, W. (2002). Two-year

safety and efficacy of inhaled human insulin (Exubera) in adult patients with type 1

diabetes. Diabetes Care 30: 579-585.

Smart, J. D. (2005). Buccal drug delivery. Expert Opinion on Drug Delivery 2: 507-

517.

Smith, P. L., Wall, D. A., Gochoco, C. H. and Wilson, G. (1992). Oral absorption of

peptides and proteins. Advanced Drug Delivery Reviews 8: 253-290.

Smith, A. M., Woods, T. J., Williams, D. J., Delcher, H. K., Eppstein, J. A. and

Mcrae, M. S. (2002). Transdermal basal insulin delivery through microspheres.

Diabetes 51: A47.

Smith, J., Wood, E. and Dornish, M. (2004). Effect of chitosan on epithelial cell tight

junctions. Pharmaceutical Research 21: 43-49.

Snyman, D., Hamman, J. H,. Kotze´, J. S., Rollings, J. E. and Kotze´, A. F. (2002)

The relationship between the absolute molecular weight and the degree of

quaternization of N-trimethyl chitosan chloride. Carbohydrate Polymers 50: 145-50.

Solomonidou, D., Cremer, K., Krumme, M. and Kreuter, J. (2001). Effect of

carbomer concentration and degree of neutralization on the mucoadhesive properties

of polymer films. Journal of Biomateral Sciences 12: 1191-1205.

Sonksen, P. and Sonksen, J. (2000). Insulin: understanding its action in health and

disease. British Journal of Anaesthesia 85: 69-79.

Spitael, J., and Kinget, R. (1977). Factors affecting the dissolution rate of enteric

coatings. Pharmazeutische Industrie 39: 502-505.

Spitael, J., Kinget, R., and Naessens, K. (1980). Dissolution rate of cellulose acetate

phthalate and Bronsted catalysis. Pharmazeutische Industrie 42: 846-849.

Sriamornsak, P., Thirawong, N., Nunthanid, J., Puttipipatkhachorn, S., Thongborisute,

J. and Takeuchi, H. (2008). Atomic force microscopy imaging of novel self-

assembling pectin-liposome nanocomplexes. Carbohydrate Polymers 71(2): 324-29.

169

Still, J. G. (2002). Development of oral insulin: progress and current status. Diabetes

Metabolism Research and Reviews 18 (Suppl.1): S29-S37.

Stoll, B. R., Leipold, H. R., Milstein, S. and Edwards, D. A. (2000). A mechanistic

analysis of carrier-mediated oral delivery of protein therapeutics. Journal of

Controlled Release 64: 217-228.

Su, X. Y. and Po, A. L. W. (1994). Surface-response study of the effect of pH and

tonicity on ciliary activity. S.T.P. Pharma Sciences 4: 82-85.

Sutherland, D. E., Goetz, F. C. and Sibley, R. K. (1989). Recurrence of disease in

pancreas transplants. Diabetes 38: 85-87.

Sutherland, D. E., Gruessner, A. and Hering, B. J. (2004). Beta-cell replacement

therapy (pancreas and islet transplantation) for treatment of diabetes mellitus: an

integrated approach. Endocrinology and Metabolism Clinics of North America 33:

135-148.

Suzuki, A., Morishita, M., Kajita, M., Takayama, K., Isowa, K., Chiba, Y., Tokiwa, S.

and Nagai, T. (1998). Enhanced colonic and rectal absorption of insulin using a

multiple emulsion containing eicosapentaenoic acid and docosahexaenoic acid.

Journal of Pharmaceutical Sciences 87: 1196-1202.

Swenson, E. S., and Curatolo, W. J. (1992). Intestinal permeability enhancement for

proteins, peptides and other polar drugs: Mechanisms and potential toxicity. Advanced

Drug Delivery Reviews 8: 39-92.

Swenson, E. S., Milisen, W. B. and Curatolo, W. (1994). Intestinal permeability

enhancement: Efficacy, acute local toxicity, and reversibility. Pharmaceutical

Research 11: 1132-1142.

Takaori, K., Burton, J. and Donawitz, M. (1986). The transport of an intact

oligopeptide across adult mammalian jejunum. Biochemical and Biophysical

Research Communications 137: 682-687.

Takeuchi, H., Matsui, Y., Sugihara, H., Yamamoto, H. and Kawashima, Y. (2005).

Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of

peptide drugs. International Journal of Pharmaceutics 303: 160-170.

Takeuchi, H., Matsui, Y., Yamamoto, H. and Kawashima, Y. (2003). Mucoadhesive

properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral

administration of calcitonin to rats. Journal of Controlled Release 862: 235-242.

Takeuchi, H., Yamamoto, H. and Kawashima, Y. (2001). Mucoadhesive

nanoparticulate systems for peptide drug delivery. Advanced Drug Delivery Reviews

47: 39-54.

Takeuchi, H., Yamamoto, H., Niwa, T., Hino, T. and Kawashima, Y. (1996). Enteral

absorption of insulin in rats from mucoadhesive chitosan-coated liposomes.

Pharmaceutical Research 13: 896-901.

170

Tan, A., Simovic, S., Davey, A. K., Rades, T. and Prestidge, C. A. (2009). Silica-lipid

hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs.

Journal of Controlled Release 134: 62-70.

Taylor, P. (2005a). Sep, 09. Headlines, Materials and Formulations. <http: //www.in-

pharmatechnologist.com/Materials-Formulation/Inhaled-insulin-gets-green-light-

from-FDA-panel>. Accessed on 2006 Jan, 10.

Taylor, P. (2005b). May. 04. Headlines, Materials and Formulations. <http: //www.in-

pharmatechnologist.com/Materials-Formulation/Non-injectable-insulin-debuts-in-

Ecuador>Accessed 2006 Jan 10.

Taylor, N. (2009). Jul, 30. Headlines, Materials and Formulation. < http: //www.in-

pharmatechnologist.com/Materials-Formulation/Medingo-s-insulin-patch-approved-

shares-rocket> Accessed 2010 Jan, 5.

Teo, M. A. L., Shearwood , C., Ng, K. C., Lu, J. and Moochhala, S. (2005). In vitro

and in vivo characterization of MEMS microneedles. Biomedical Microdevices 7: 47-

52.

Thanou, M., Verhoef, J. C. and Junginger, H. E. (2001). Chitosan and its derivatives

as intestinal absorption enhancers. Advanced Drug Delivery Reviews 50 (Suppl 1):

S91-S101.

The DCCT Research Group (1993). The effect of intensive treatment of diabetes on

the development and progression of long-term complications in insulin-dependent

diabetes mellitus. The New England Journal of Medicine 329: 977-986.

The Medical News. (2009). Sep, 30. News. <http: //www.news-

medical.net/news/20090930/AFRESA-Inhalation-Powder-and-AFRESA-Inhaler-

NDA-under-FDA-review.aspx >. Accessed 2010 Jan. 05.

Thirawong, N., Thongborisute, J., Takeuchi, H. and Sriamornsak, P. (2008b)

Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel

pectin-liposome nanocomplexes. Journal of Controlled Release 125: 236-45.

Tiwari, D., Goldman, D., Sause, R. and Madan, P. L. (1999). Evaluation of

polyoxyethylene homopolymers for buccal bioadhesive drug delivery device

formulations. AAPS PharmSci 1: E13.

Tomita, M., Hayashi, M. and Awazu, S. (1995). Absorption-enhancing mechanism of

sodium caprate and decanoylcarnitine in Caco-2 cells. Journal of Pharmacology and

Experimental Therapeutics 272: 73-743.

Touitou, E., and Donbrow, M. (1983). Promoted rectal absorption of insulin:

Formulative parameters involved in the absorption from hydrophilic bases.

International Journal of Pharmaceutics 15: 13-24.

171

Touitou, E., Donbrow, M. and Azaz, E. (1978). New hydrophilic vehicle enabling

rectal and vaginal absorption of insulin, heparin, phenol red and gentamicin. Journal

of Pharmacy and Pharmacology 30: 662-663.

Touitou, E., Donbrow, M. and Rubinstein, A. (1980). Effective intestinal absorption

of insulin in diabetic rats using a new formulation approach. Journal of Pharmacy and

Pharmacology 32: 108-110.

Touitou, E., and Rubinstein., A. (1986). Targeted enteral delivery of insulin to rats.

International Journal of Pharmaceutics 30: 95-99.

Turner, R. C., Millns, H., Neil, H. A., Stratton, I. M., Manley, S. E., Matthews, D. R.,

Holman, R. R. (1998). Risk factors for coronary artery disease in non-insulin

dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:

23). British Medical Journal 316: 823-828.

Twentyman, P. R. and Bleehen, N. M. (1991). Resistance modification by PSC-833, a

novel nonimmunosuppressive cyclosporin. European Journal of Cancer 27:1639–

1642.

Uchegbu, I. F. and Vyas, S.P. (1998). Non-ionic surfactant based vesicles (niosomes)

in drug delivery. International Journal of Pharmaceutics 172: 33-70.

Uchiyama, T., Sugiyama, T., Quan, Y. S., Kotani, A., Okada, N., Fujita, T.,

Muranishi, S. and Yamamoto, A. (1999). Enhanced permeability of insulin across the

rat intestinal membrane by various absorption enhancers: their intestinal mucosal

toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.

Journal of Pharmacy and Pharmacology 51: 1241-1250.

Uchiyama, T., Yamamoto, A., Hatano, H., Fujita, T. and Muranishi, S. (1996)

Effectiveness toxicity screening of various absorption enhancers in the large intestine:

intestinal absorption of phenol red and protein and phospholipid release from the

intestinal membrane. Biological and Pharmaceutical Bulletin 19: 1618-1621.

Unger, R. H. (2003). Minireview: Weapons of lean body mass destruction: the role of

ectopic lipids in the metabolic syndrome. Endocrinology 144: 5159-5165.

Unger, R. H. (2008). Reinventing type 2 diabetes: pathogenesis, treatment, and

prevention. Journal of Americal Medical Association 299: 1185-1187.

Ushirogawa, Y., Nakahigashi, Y., Kiriyama, A. and Takada, K. (1992). Effect of

organic acids, trypsin inhibitors and dietary protein on the pharmacological activity of

recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.

Internationa Journal of Pharmaceutics 81: 133-141.

Utoguchi, N., Utoguchi, N., Watanabe, Y., Shida, T. and Matsumoto, M. (1998).

Nitric oxide donors enhance rectal absorption of macromolecules in rabbits.

Pharmaceutical Research 15: 870-876.

van Asperen, J., van Tellingen, O., Sparreboom, A., Schinkel, A. H., Borst, P.,

Nooijen, W. J. and Beijnen, J. H. (1997). Enhanced oral bioavailability of paclitaxel

172

in mice treated with the Pglycoprotein blocker SDZ PSC 833. British Journal of

Cancer 76: 1181–1183.

van Hoogdalem, E. J., Heijligers-Feijen, C. D., Mathot, R. A., Wackwitz, A. T. van

Bree, J. B., Verhoef, J. C., De Boer A. G. and Breimer, D. D. (1989). Rectal

absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by

sodium tauro-24,25-dihydrofusidate in conscious rats. Journal of Pharmacology and

Experimental Therapeutics 251: 741-744.

Varma, M. V. and Panchagnula, R. (2005). Enhanced oral paclitaxel absorption with

vitamin ETPGS: effect on solubility and permeability in vitro, in situ and in vivo.

European Journal of Pharmaceutical Sciences 25: 445–453.

Varma, M. V., Ashokraj, Y., Dey, C. S. and Panchagnula, R. (2003). P-glycoprotein

inhibitors and their screening: A perspective from bioavailability enhancement.

Pharmacological Research 48: 347–359.

Varma, M. V., Perumal, O. P. and Panchagnula, R. (2006). Functional role of P-

glycoprotein in limiting peroral drug absorption: optimizing drug delivery. Current

Opinion in Chemical Biology 10: 367–373.

Varshosaz, J., Pardakhty, A., Hajhashemi, V. I. and Najafabadi, A. R. (2003).

Development and physical characterization of sorbitan monoester niosomes for

insulin oral delivery. Drug Delivery 10: 251-262.

Vaughn, D. E., Yocum, R. C., Muchmore, D. B., Sugarman, B. J., Vick, A. M.,

Bilinsky, I. P. and Frost, G. I. (2009). Accelerated Pharmacokinetics and

Glucodynamics of Prandial Insulins Injected With Recombinant Human

Hyaluronidase. Diabetes Technology and Therapeutics 11: 345-352.

Veillard, M. M., Longer, M. A., Martens, T. W., Robinson, J. R. (1987). Preliminary

studies of oral mucosal delivery of peptide drugs. Journal of Controlled Release 6:

123-131.

Verge, D. (2004). Biotechnological and administration innovations in insulin therapy.

Medicine Sciences (Paris) 20: 986-998.

Victor, S. P. and Sharma, C. P. (2002). Stimuli sensitive polymethacrylic acid

microparticles (PMAA) - oral insulin delivery. Journal of Biomaterials Applications

17: 125-134.

Walker, B., McCarthy, N., Healy, A., Ye, T. and McKervey, M. A. (1993). Peptide

gyoxals-a novel class of inhibitor for serine and cysteine proteinases. The Biochemical

Journal 193: 321-323.

Wan, J. and Shen, W. -C. (1991). Brefeldin A And Monensin Enhance Transferrin

Receptor-Mediated Protein Transport Across Epithelial Cells. Pharmaceutical

Research 8: Suppl: s-4.

173

Wang, W., Uzzau, S., Goldblum, S. and Fasano, A. (2000). Human Zonulin, a

potential modulator of intestinal tight junctions. Journal of Cell Science 113: 4435–

4440.

Watanabe, K., Sawano, T., Jinriki, T. and Sato, J. (2004). Studies on intestinal

absorption of sulpiride (3): Intestinal absorption of sulpiride in rats. Biological and

Pharmaceutical Bulletin 27: 77-81.

Watts, P. and Illum, L. (1997). Colonic drug delivery. Drug Development and

Industrial Pharmacy 23: 893-913.

Watts, T., Berti, I., Sapone, A., Gerarduzzi, T., Not, T., Zielke, R. and Fasano, A.

(2005). Role of the intestinal tight junction modulator zonulin in the pathogenesis of

type I diabetes in BB diabetic-prone rats. Proceedings of the National Academy of

Sciences of USA 102: 2916–2921.

Werner, U., Kissel, T. and Reers, M. (1996) Effects of permeation enhancers on the

transport of a peptidomimetic thrombin inhibitor (CRC 220) in a human intestinal cell

line (Caco-2). Pharmaceutical Research 13: 1219-1227.

Werner, U., Kissel, T. and Stüber, W. (1997). Effects of peptide structure on transport

properties of seven thyrotropin releasing hormone (TRH) analogues in a human

intestinal cell line (Caco-2). Pharmaceutical Research 14: 246-250.

Wiley, R. A. (2002). Insulin and oral hypoglycemic drugs. Williams, D. A., Foye, W.

O. and Lemke, T. L. (eds) In: Foye’s principles of medicinal chemistry. pp. 629-632.

Lippincott Williams and Wilkins, Philadelphia, Pennsylvania, USA.

Wilson, C. G., Washington, C. and Washington, N. (1989). The stomach: its role in

oral drug delivery. In; Wilson, C. G. and Washington, N. (eds). Physiological

Pharmaceutics. pp. 47-70. Ellis Horwood Limited, Chichester.

Woo, J. S., Lee, C. H., Shim, C. K. and Hwang, S. J. (2003). Enhanced oral

bioavailability of paclitaxel by coadministration of the P-glycoprotein inhibitor

KR30031. Pharmaceutical Research 20: 24–30.

Woodley, J. (2001). Bioadhesion: New possibilities for drug administration. Clinical

Pharmacokinetics 40: 77-84.

Woolfson, A. D., Malcom, R. K. and Gallagher, R.. (2000). Drug delivery by the

intravaginal route. Critical Reviews in Therapeutic Drug Carrier Systems 17: 509-

555.

Wrinch, D. M. (1937). On the structure of insulin. Transactions of the Faraday

Society 33: 1368-1380.

Wu, S. -J. and Robinson, J. R. (1999). Transcellular lipophilic complex-enhanced

intestinal absorption of human growth hormone. Pharmaceutical Research 16: 1266-

1272.

174

Wu, Z. H., Ping, Q. N., Wei, Y. and Lai, J. M. (2004). Hypoglycemic efficacy of

chitosan-coated insulin liposomes after oral administration in mice. Acta

Pharmacologica Sinica 25: 966-972.

Yamamoto, A., Hayakawa, E., Kato, Y., Nishiura, A. and Lee, V. H. L. (1992). A

mechanistic study on enhancement of rectal permeability to insulin in the albino

rabbit. Journal of Pharmacology and Experimental Therapeutics 263: 25-31.

Yamamoto, A., Okagawa, T., Kotani, A., Uchiyama, T., Shimura, T., Tabata, S.,

Kondo, S. and Muranishi, S. (1997). Effects of different absorption enhancers on the

permeation of ebiratide, an ACTH analogue, across intestinal membranes. Journal

Pharmacy and Pharmacology 49: 1057-1061.

Yamamoto, A., Taniguchi, T., Rikyun, K., Tsuji, T., Fujita, T., Murakami, M. and

Muranishi, S. (1994). Effects of Various Protease Inhibitors on the Intestinal

Absorption and Degradation of Insulin in Rats. Pharmaceutical Research 11: 1496-

1500.

Yamamoto, A., Tatsumi, H., Maruyama, M., Uchiyama, T., Okada, N. and Fujita, T.

(2001). Modulation of intestinal permeability by nitric oxide donors: implications in

intestinal delivery of poorly absorbable drugs. Journal of Pharmacology and

Experimental Therapeutics 296: 84–90.

Yamamoto, A., Uchiyama, T., Nishikawa, R., Fujita, T. and Muranishi, S. (1996).

Effectiveness and toxicity screening of various absorption enhancers in the rat small

intestine: effects of absorption enhancers on the intestinal absorption of phenol red

and the release of protein and phospholipids from the intestinal membrane. J. Pharm.

Pharmacol 48: 1285-1289.

Yamashita, S., Saitoh, H., Nakanishi, K., Masada, M., Nadai, T. and Kimura, T.

(1987). Effects of diclofenac sodium and disodium ethylenediaminetetraacetate on

electrical parameters of the mucosal membrane and their relation to the permeability

enhancing effects in the rat jejunum. Journal of Pharmacy and Pharmacology 39:

621–626.

Yang, X., Ko, G. T., So, W. Y., Ma, R. C., Yu, L. W., Kong, A. P., Zhao, H., Chow,

C. C., Tong, P. C. and Chan, J. C. (2010). Associations of hyperglycemia and insulin

usage with the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry.

Diabetes 59: 1254-1260.

Yang, C., Tirucherai, G. S. and Mitra, A. K. (2001). Prodrug based optimal drug

delivery via membrane transporter/receptor. Expert Opinion on Biological Therapy 1:

159-175.

Yang, Y. X., Hennessy, S., Lewis, J. D. (2004). Insulin therapy and colorectal cancer

risk among type 2 diabetes mellitus patients. Gastroenterology 127: 1044-1050.

175

Yoshida, H., Lehr, C. -M., Kok, W., Junginger, H. E., Verhoel, J. C. and Bouwstra, J.

A. (1992). Niosomes for oral delivery of peptide drugs. Journal of Controlled Release

21: 145-153.

Yoshioka, S., Caldwell, L. and Higuchi, T. (1982). Enhanced rectal bioavailability of

polypeptides using sodium 5-methoxysalicylate as an absorption promoter. Journal of

Pharmaceutical Sciences 71: 593-594.

Young, J. D. and Carpenter, F. H. (1961). Isolation and Characterization of Products

Formed by the Action of Trypsin on Insulin. Journal of Biological Chemistry. 236:

743-748.

Zahirul, M., Khan, I., Prebeg, Z. and Kurjakovic, N. (1999). A pH-dependent colon

targeted oral drug delivery system using methacrylic acid copolymers. I. Manipulation

of drug release using Eudragit™ L100-55 and Eudragit™ S 100 combinations.

Journal of Controlled Release. 58: 215-222.

Zhang, H., Yao, M., Morrison, R. A. and Chong, S. (2003). Commonly used

surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in

rats. Archives of Pharmacal Research 26: 768–772.